SCHEMBL6686581

SCHEMBL6686581

CC(=O)COC(C)(C)C

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL11989018 0.83 MGAM (0.32)
SCHEMBL11236691 0.80
SCHEMBL12123157 0.79 CES2 (0.31)
SCHEMBL15131909 0.79 MAPK1 (0.38)
SCHEMBL7682659 0.77 TSHR (0.41)
SCHEMBL11131624 0.77
SCHEMBL431399 0.77
SCHEMBL6743732 0.76 ALDH1A1 (0.38)
SCHEMBL26316213 0.76 DGAT1 (0.40)
SCHEMBL4208343 0.75

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 74 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0764625-B1 Process for improving the storability of liquid hydroxy- and alkoxyalkylketones BASF AG (DE) 1999-04-07 EP claimed
US-5874631-A ADDING FROM 0.0001 TO 1% BY WEIGHT OF A TERTIARY AMINE, OR GROUP 1A AND 2A HYDROXIDES AND CARBONATES OR MIXTURES THEREOF BASF AKTIENGESELLSCHAFT (DE) 1999-02-23 US claimed
EP-0764625-A1 Process for improving the storability of liquid hydroxy- and alkoxyalkylketones BASF AKTIENGESELLSCHAFT (DE) 1997-03-26 EP claimed
EP-4590676-A1 HEXAHYDRO-2H-PYRIDO[2,1-A]ISOQUINOLINE VMAT2 INHIBITORS AND METHODS OF USE Neurocrine Biosciences, Inc. (US) 2025-07-30 EP disclosed
CN-119907800-A Hexahydro-2H-pyrido [2,1-a ] isoquinoline VMAT2 inhibitors and methods of use thereof 纽罗克里生物科学有限公司 2025-04-29 CN disclosed
WO-2024064178-A1 HEXAHYDRO-2H-PYRIDO[2,1-A]ISOQUINOLINE VMAT2 INHIBITORS AND METHODS OF USE NEUROCRINE BIOSCIENCES, INC. (US) 2024-03-28 WO disclosed
US-11826328-B2 Stable treprostinil prodrugs UNITED THERAPEUTICS CORPORATION (US) 2023-11-28 US disclosed
CN-117062808-A Crystalline solid meglumine salt inhibitors of BCL and methods of making and using the same 联合生物科技公司 2023-11-14 CN disclosed
CN-111670186-B Pyrazolopyridine-diamides, their use as pesticides and process for their preparation PI工业有限公司 2023-10-17 CN disclosed
US-20230279023-A1 N/O-Linked Degrons and Degronimers for Protein Degradation C4 THERAPEUTICS, INC. (US) 2023-09-07 US disclosed
US-20230159504-A1 7- OR 8-HYDROXY-ISOQUINOLINE AND 7- OR 8-HYDROXY-QUINOLINE DERIVATIVES AS ALPHA-1-ANTITRYPSIN MODULATORS FOR TREATING ALPHA-1-ANTITRYPSIN DEFICIENCY (AATD) VERTEX PHARMACEUTICALS INCORPORATED 2023-05-25 US disclosed
EP-0506068-A1 Oxidation of terminal olefins to aldehydes UNION CARBIDE CHEMICALS & PLASTICS TECHNOLOGY CORPORATION (US) 1992-09-30 EP disclosed
US-5136105-A Catalytic reaction in presence of alcohol UNION CARBIDE CHEMICALS & PLASTICS TECHNOLOGY CORPORATION (US) 1992-08-04 US disclosed
US-4515975-A Chroman derivatives and their preparation BASF AKTIENGESELLSCHAFT (DE) 1985-05-07 US disclosed
EP-0052731-B1 CHROMAN DERIVATIVES AND METHOD FOR THEIR PREPARATION BASF Aktiengesellschaft (DE) 1985-04-17 EP disclosed
US-4440779-A Tricyclic derivatives of substituted pyrrole acids as analgesic and anti-inflammatory agents MERCK & CO., INC. (US) 1984-04-03 US disclosed
EP-0068460-A1 Tricyclic derivatives of substituted pyrrole acids as analgesic and anti-inflammatory agents MERCK & CO. INC. (US) 1983-01-05 EP disclosed
EP-0052731-A1 Chroman derivatives and method for their preparation BASF Aktiengesellschaft (DE) 1982-06-02 EP disclosed
US-4229262-A EXTRACTIVE DISTILLATION UNION CARBIDE CORPORATION (US) 1980-10-21 US disclosed
US-4153516-A SOLVENT EXTRACTION WITH AN ALCOHOL SOLVENT UNION CARBIDE CORPORATION (US) 1979-05-08 US disclosed